CAS: 1862212-48-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
TH 1217 REF: IN-DA01LQLLCAS: 1862212-48-3 | 98% | A consultar | Mar 21 Ene 25 | |
TH1217 REF: TM-T38271CAS: 1862212-48-3 | 99.3% | A consultar | Mar 11 Mar 25 | |
TH 1217 REF: 3D-MZC21248CAS: 1862212-48-3 | Min. 95% | - - - | Producto descatalogado |
Ref: IN-DA01LQLL
5mg | 288,00 € | ||
10mg | 473,00 € | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
TH1217
CAS:1862212-48-3
TH1217: potent dCTPase inhibitor, IC50=47 nM; boosts cytidine analogues in leukemia, may affect COVID-19.
Fórmula:
C20H17BCl2N4O6
Pureza:
99.3%
Forma y color:
Liquid
Peso molecular:
491.09
Ref: TM-T38271
1mg | 38,00 € | ||
5mg | 82,00 € | ||
10mg | 122,00 € | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025
TH 1217
CAS:1862212-48-3
TH 1217 is a peptide that was originally isolated from human serum by affinity chromatography. …
Fórmula:
C20H17BCl2N4O6
Pureza:
Min. 95%
Peso molecular:
491.1 g/mol
Ref: 3D-MZC21248
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |